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The oxygen-dependent hydroxylation of proline resi-
dues in the a subunit of hypoxia-inducible transcrip-
tion factor (HIFa) is central to the hypoxic response in
animals. Prolyl hydroxylation of HIFa increases its
binding to the von Hippel-Lindau protein (pVHL), so
signaling for degradation via the ubiquitin-protea-
some system. The HIF prolyl hydroxylases (PHDs,
prolyl hydroxylase domain enzymes) are related to
the collagen prolyl hydroxylases, but form unusually
stable complexes with their Fe(II) cofactor and 2-ox-
oglutarate cosubstrate. We report crystal structures
of the catalytic domain of PHD2, the most important
of the human PHDs, in complex with the C-terminal
oxygen-dependent degradation domain of HIF-1a.
Together with biochemical analyses, the results
reveal that PHD catalysis involves a mobile region
that isolates the hydroxylation site and stabilizes
the PHD2.Fe(II).2OG complex. The results will be of
use in the design of PHD inhibitors aimed at treating
anemia and ischemic disease.
INTRODUCTION
The ab-heterodimeric hypoxia-inducible factor (HIF) enables
transcription of a set of genes, the products of which allow cells
to adapt to hypoxia in metazoans (Epstein et al., 2001; Kaelin,
2005; Schofield and Ratcliffe, 2004). In contrast to HIFb, the
levels of which are not directly regulated by oxygen, both the
stability and transcriptional activity of HIFa are regulated by
oxygen availability (Chowdhury et al., 2008; Schofield and Rat-
cliffe, 2004). In humans, the posttranslational 4R-hydroxylation
of two proline residues (Pro-564 and Pro-402) located within
N- and C-terminal oxygen-dependent degradation domains of
HIF-1a (NODD and CODD, respectively) can be catalyzed by
one of three 2-oxoglutarate (2OG) dependent prolyl hydroxy-
lases (human PHD 1, 2, or 3) (Chowdhury et al., 2008; Schofield
and Ratcliffe, 2004; Semenza, 2007). HIFa prolyl-hydroxylation
significantly increases binding of HIFa to the von Hippel-Lindau
suppressor protein (pVHL), which acts as the recognition
component of an E3 ubiquitin ligase that targets HIFa for degra-Structure 17dation by proteasomes (see Figure S1 available online) (Ivan
et al., 2001; Jaakkola et al., 2001; Maxwell et al., 1999). Under
hypoxia, HIFa avoids pVHL-mediated degradation and translo-
cates to the nucleus where it dimerizes with HIFb, to activate
the transcription of target genes by binding to a core hypoxia
response element (HRE) DNA sequence (Semenza, 2001;
Wang et al., 1995). Interaction of HIFa with the p300/CBP coac-
tivator complex is also regulated by oxygen; b-hydroxylation of
Asn-803 (in human HIF-1a) within the HIFa C-terminal transacti-
vation domain, as catalyzed by another 2OG oxygenase, factor
inhibiting HIF (FIH), blocks the HIF-p300 interaction (Hewitson
et al., 2002; Lando et al., 2002).
The HIF hydroxylases have an absolute requirement for dioxy-
gen, with one of the dioxygen atoms being incorporated into the
hydroxylated product and one into the succinate coproduct
(McNeill et al., 2002; Welford et al., 2005). The KM value of
PHD2 for oxygen is reported to be significantly higher than the
binding constants for 2OG and long HIFa fragments (Ehrismann
et al., 2007; Hirsila et al., 2003), a property proposed to be impor-
tant in the role of PHD2 as the most important oxygen sensor in
normal animal cells (Figure S1) (Schofield and Ratcliffe, 2004;
Takeda et al., 2006). PHD2 is also highly unusual among studied
2OG oxygenases in that it forms a long-lived complex with Fe(II)
and 2OG, even under aerobic conditions (McNeill et al., 2005). To
gain a molecular understanding of how the PHDs act as oxygen
sensors in normal and disease states, information on how they
bind HIFa is required.
Structures of the catalytic domain of PHD2 (tPHD2) in
complex with Fe(II) and inhibitors that compete with 2OG (Fig-
ure S2) have revealed the archetypical iron binding motif and
double-stranded b helix (DSBH) fold of the 2OG oxygenases,
including prokaryotic proline-hydroxylases and the procollagen
prolyl-hydroxylases (Clifton et al., 2001, 2006; Koski et al.,
2007; McDonough et al., 2006). These structures have provided
limited insight into the reasons for the unusual properties of
PHD2.
Here we report crystal structures of the catalytic domain of
PHD2 in complex with a peptide representing its HIF-1a CODD
substrate which reveal that the substrate prolyl-residue is bound
in a specific conformation and that a significant structural
change involving a mobile loop likely occurs concomitant with
HIFa binding. Together with biochemical analyses, the results
reveal that PHD catalysis involves a mobile region that isolates
the active site and stabilizes the PHD2.Fe(II).2OG complex., 981–989, July 15, 2009 ª2009 Elsevier Ltd All rights reserved 981
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Crystallization of tPHD2.HIFa Complex
Although PHD2 protein is monomeric in solution, tPHD2.Fe(II).in-
hibitor (hereafter tPHD2.Fe(II).A/B) complexes crystallize in an
apparently homotrimeric form (space group P63, Figure S2)
(McDonough et al., 2006). A and B are bicyclic inhibitors that
bind to the active site iron in these structures (see Figure S2
for A and B). Initially we attempted to obtain a PHD2-substrate
structure with this crystal form: After optimization, soaking
tPHD2.Fe(II).B crystals with 4R-Pro-564 hydroxylated HIF-
1a556-574(Hyp564) (CODDHyp564), a 19-residue fragment of the
larger 150 residue CODD domain, which is hydroxylated by
PHD2 (Ehrismann et al., 2007; Epstein et al., 2001), yielded
a 2.3 A˚ resolution structure (space group P63) with CODD
residues 568–574 apparent in the electron density maps and
located in a groove on the tPHD2 surface. However, density
was not observed for hydroxylated Pro-564 and adjacent resi-
dues, apparently because in this crystal form the C-terminal helix
(a4) of a symmetry-related molecule blocks the active site
(Figure 1).
We then attempted a series of experimental approaches to
obtain a PHD2.HIFa complex structure more representative of
a catalytically active complex. In one approach, tPHD2 variants
aimed at specifically destabilizing homotrimer formation as
observed in the P63 crystal form were produced (Figure S2). In
the presence of N-oxalylglycine (NOG, a near isosteric analog
of 2OG) and Mn(II), substituting for 2OG and Fe(II), respectively,
the Arg398Ala tPHD2 variant produced crystals within 6 months.
Arg398Ala.Mn(II).NOG.HIF-1aCODD556-574 (hereafter tPHD2.
CODD) complex crystallized in space group P212121 (Figures
2A and S3). The structure was solved by molecular replacement
(search model: Protein Data Bank [PDB] ID code 2G19) and
refined to 2.0 A˚ resolution (Rfactor = 0.234 and Rfree = 0.248)
(Table 1).
Figure 1. The HIFa Binding Site of PHD2 and Compar-
ison of the tPHD2.Fe(II).B.CODDHyp564 (tPHD2.COD-
DHyp564) with the Arg398Ala tPHD2.Mn(II).NOG.CODD
(tPHD2.CODD) Structures
(A) Surface representation of tPHD2.CODDHyp564 complex
(cyan); CODD residues 568–574 (salmon sticks) were mo-
deled. Note that the C-terminal a4 helix of a symmetry-related
tPHD2 molecule (blue ribbons) apparently ‘‘blocks’’ the active
site entrance in this crystal form. The b2b3/loop is highlighted
in red.
(B) Ribbons representation of tPHD2.CODDHyp564 complex
(cyan) in the proposed open conformation.
(C) Surface representation of tPHD2.CODD complex showing
the channel where CODD (yellow sticks) binds. The apparent
movement of residues 237–254 (b2b3/loop shown in red) is
proposed to enclose the substrate.
(D) Ribbons representation of the tPHD2.CODD complex
(green) in the proposed closed conformation.
Overall Mode of HIFa Binding
Superimposition of the tPHD2.Fe(II).A/B and
tPHD2.CODD structures revealed similar back-
bone conformations for the major (b1, b8, b5, b10,
b4) and minor (b7, b6, b9, [II] [McDonough et al.,
2006]) b sheets of the DSBH, and three (a1–3) of the four a helices
in tPHD2 (Figure 2). However, differences between the
tPHD2.Fe(II).A/B and tPHD2.CODD structures in the regions
surrounding the active site provide evidence for two mobile
elements. The most striking difference involves tPHD2 residues
237–254, which adopt a finger-like ‘‘b2b3’’ conformation in the
P63 crystal form, but adopt a loop conformation in the
tPHD2.CODD structure (the Ca position of Ser-242 differs by
18A˚ between the two structures). The b2b3/loop folds to
entirely enclose the Pro-564 region of the HIFa peptide and the
tPHD2 active site (these residues are referred to as the b2b3/
loop shown in red in Figure 1C, see below). The other region of
difference involves a smaller change in the C-terminal helix a4
(the Ca position of Lys-400 differs by 2.5A˚ between the two
structures). The substrate is bound in the same cleft in both
the tPHD2.CODD and P63 CODD complex structures, though
only in the former case do the Pro-564 and surrounding residues
bind at the active site. Thus, the conformations observed in the
tPHD2.CODD structure likely better represent the structure of
a catalytically productive complex than those in the P63 form.
Molecular dynamics simulations were carried out to investigate
the conformation of the tPHD2.Fe(II).2OG.CODD complex,
which was modeled on the basis of the crystallographically
observed tPHD2.CODD structure. As observed in the crystalline
state with Mn(II) substituting for Fe(II) and NOG for 2OG, the
results predict that, in solution, the overall structure of the
tPHD2.Fe(II).2OG.CODD complexwill be similar to that observed
for the analogous crystal structure with Mn(II) and NOG
(Figure S4).
In the tPHD2.CODD structure, CODD binds to tPHD2 in a well-
defined cleft and adopts a largely ‘‘loosely’’ extended form
including several bends, but with an N-terminal single turn 310-
helix (CODD residues 559–562) (Figures 1 and S3B). From the
N terminus, CODD interacts with the following elements of
PHD2: (II), the b2b3/loop, b10, the C-terminal helix a4, the loop982 Structure 17, 981–989, July 15, 2009 ª2009 Elsevier Ltd All rights reserved
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bonds between the main-chain carbonyl O of Ala-563CODD with
the backbone amide NH of Val-241PHD2 in the b2b3/loop, and
between the backbone carbonyl of Pro-564CODD and side chain
of Arg-322PHD2 apparently help to position the target Pro-
564CODD directly adjacent to the metal (Table S1).
The hydroxylation sites of both NODD and CODD of HIFa
occur within a conserved LXXLAP motif (Masson et al., 2001).
In the tPHD2.CODD structure, Leu-559CODD, Leu-562CODD,
and Ala-563CODD of the LXXLAP motif form part of the CODD
310-helix and are apparently positioned to make hydrophobic
interactions with tPHD2 (Table S1 and Figure S5). The binding
site of Leu-559CODD is apparently formed by the side chains of
Val-314PHD2 and Pro-317PHD2, whereas that of Leu-562CODD is
formed by the side chains of Ile-251PHD2, Val-311PHD2, and Cb
of His-313PHD2, which also coordinates to the active site iron
(see below). Other apparent hydrophobic interactions between
CODD and tPHD2 occur between the side chain of Leu-
574CODD, which is important for HIF-1a hydroxylation in cells
(Kageyama et al., 2004), and a hydrophobic pocket in tPHD2,
formed by the side chains of Ile-280, Ile-292, Tyr-390, and Arg-
281/Arg-295 (via their methylenes) (Figure S5).
Conformational Changes on Substrate Binding Implied
by the Crystallographic Analyses
Although it is likely that the solution structures of PHD2 are not
fully represented by the available crystal structures, the combi-
nation of crystallographic and other biophysical and biochemical
analyses indicates that significant conformational changes are
involved in the binding of CODD to tPHD2. Previous compari-
sons between crystal structures of 2OG oxygenases and related
oxidases in the absence or presence of (co)substrates have re-
vealed only relatively minor structural differences upon binding
of substrates (Roach et al., 1997; Strieker et al., 2007). However,
nuclear magnetic resonance and mass spectrometric (MS) anal-
yses of tPHD2 and another 2OG oxygenase, AlkB, have shown
that significant stabilization occurs on 2OG/inhibitor binding,
implying that the available crystallographic analyses are not
entirely representative (Bleijlevens et al., 2008; Stubbs et al.,
2009). In order for CODD to bind to PHD2, it seems unlikely
that the b2b3/loop (residues 237–254) of tPHD2 adopts the
conformation observed in the tPHD2.CODD structure because
the active site would be blocked (Figure 2). Although the
finger-like conformation (b2b3) of residues 237–254 observed
in the P63 crystal form might in part result from specific crystal
contacts, it seems likely that it, or a related conformation, might
enable an ‘‘open’’ active site capable of productively binding
CODD. Following, or concomitant with, CODD binding, the
same residues (i.e., the b2b3/loop from Thr-236) can form an
extended loop and a 310-helix (residues 248–251), as observed
in the tPHD2.CODD structure, that can entirely enclose the
conserved LXXLAP motif of CODD (Figure 2). Interactions
between the b2b3/loop residues and CODD include two back-
bone-to-backbone hydrogen bonds and hydrophobic contacts
(Table S1). The base of the b2b3/loop is apparently anchored
at the active site by a salt bridge between Arg-252PHD2 and
Asp-254PHD2 (Figure 2). Binding of bicyclic aromatic inhibitors
to the active site will disrupt this salt bridge, consistent with
the open active site state observed in the P63 crystal form.Structure 17tPHD2 variants in which either the b2b3/loop was deleted
(Flashman et al., 2008) or residues apparently important in stabi-
lizing the ‘‘enclosed’’ conformation were substituted (Arg252Ala,
Asp254Lys, Asp254Ala, Figure 2D) demonstrated significantly
reduced CODD hydroxylation (<25%) compared with tPHD2
(Figures 2E and 2F and Table S2). Notably, nondenaturing
mass spectrometry studies showed that the Asp254Lys and
Asp254Ala variants, and the b2b3/loop deletion variants, formed
less stable 2OG complexes than tPHD2 (Figure S6), but in
activity assays they displayed increased 2OG turnover, both in
the absence and presence of CODD (Figures 2E, 2F, and S7A).
Overall, the crystallographic and solution results support the
proposal of a dynamic nature for the b2b3/loop and reveal that
it is important in enabling PHD2 to form stable complexes with
Fe(II) and 2OG, as well as coordinating the oxidation of 2OG
with prolyl-hydroxylation. Both of these properties are likely
required for PHD2 to act as an efficient oxygen sensor.
Compared with the P63 form, the C-terminal helix a4 in the
tPHD2.CODD complex moves toward the CODD substrate
(Figure 2). The residues of a4 facing toward the DSBH core
interact with CODD, including with a salt bridge between Asp-
571CODD and Arg-396PHD2 (this arginine residue is conserved in
PHD1-3) (Figure 2). These observations are consistent with
studies on the role of the C terminus in PHD2 catalysis: trunca-
tions after tPHD2 Lys-402 cause loss of hydroxylation activity
(Flashman et al., 2008). The Arg396Ala tPHD2 variant displayed
significantly reduced CODD, but increased NODD hydroxylation
both in assays with individual NODD/CODD substrates (Figures
2E and 2F) and in competition assays (Figure S7B). This result is
consistent with the lack of an acidic residue in an analogous
position to Asp-571CODD in NODD (Figure S8) and implies an
important role for the Asp-571CODD-Arg-396PHD2 salt bridge in
CODD catalysis.
Active Site Chemistry
HIF-1a Pro-564 is located at the apex of a shallow bend of CODD
and, like the metal [Mn(II) substituting for Fe(II)] and NOG
(substituting for 2OG, not shown), is embedded within the deep
active-site pocket. The buried nature of metal and 2OG binding
sites might reflect the unusually high affinity of tPHD2 for Fe(II)
and 2OG (see below) (McNeill et al., 2005). The 4R carbon-
hydrogen bond of Pro-564CODD that is cleaved during hydroxyl-
ation, which occurs with retention of stereochemistry (Loenarz
et al., 2009), projects toward the metal center. Interestingly, the
pyrrolidine ringofPro-564CODDadopts theC
4endoconformation,
as proposed to occur at the active site of both the PHDs (Loenarz
et al., 2009) and a procollagen prolyl-hydroxylase (Gorres et al.,
2008). In contrast, in the VCB.CODDHyp564 complex structures
(Hon et al., 2002; Min et al., 2002) the hydroxyproline (Hyp)-
564CODD residue adopts the C
4 exo conformation (Figure 3B).
Overall, these observations support proposals arising from
studies employing potential peptide substrates with Pro-
564CODD analogs that favor either the C
4 endo or the C4 exo
conformations of the prolyl-residue (Loenarz et al., 2009). Based
on turnover and binding assays, it was proposed that HIFa
prolyl-hydroxylation occurs with Pro-564 in the C4 endo confor-
mation, but following hydroxylation, a stereoelectronic effect
causes a bias to the C4 exo conformation as observed in the
VCB.CODDHyp564 complex structures (Figure 4) (Hon et al.,, 981–989, July 15, 2009 ª2009 Elsevier Ltd All rights reserved 983
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(A) Stereo view ribbons representation of the tPHD2.CODD complex structure. The tPHD2 fold comprises four a helices and ten b strands of which eight form
adouble-strandedbhelix (DSBH,darkblue) (McDonoughetal., 2006). Threeof the fourahelices (a1,a2,anda3)packalong themajorbsheetandstabilize theDSBH.
(B) Stereo view ribbons representation of the tPHD2.CODD complex structure (green) superimposed with tPHD2.Fe(II).A structure (cyan) showing structural
differences in the b2b3/loop (PHD2237-254) and C-terminal a4-helix conformations.
(C) Bicyclic inhibitors, such as A (salmon) disrupt the Arg-252:Asp-254 salt-bridge observed in the closed substrate binding conformation (P212121); they also
apparently cause rotation of Tyr-310 Cb-Cg (by 45) relative to that observed in the P63 form (not shown). Distances for selected salt bridges are given in
angstroms.
984 Structure 17, 981–989, July 15, 2009 ª2009 Elsevier Ltd All rights reserved
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structures supports these proposals by showing how the Pro-
564 C4 endo conformation, but probably not the C4 exo confor-
mation, enables a productive complex for hydroxylation of the C4
trans prolyl hydrogen atomwith the likely {FeIV = O} intermediate.
The tPHD2.CODD structure also suggests that this conforma-
tional endo to exo ‘‘switch or bias’’ might contribute to the
Table 1. Crystallographic Data Processing and Refinement
Statistics
Measurement
Arg398Ala
tPHD2.Mn(II).NOG.
CODD556-574
tPHD2.Fe(II).B.
CODD556-574(Hyp564)
Data Collection
Space group P212121 P63
Cell dimensions (A˚)
a 39.38 111.82
b 68.80 111.82
c 72.22 39.62
Resolution (A˚) 34.18-2.00 30.55-2.30
(2.07-2.00)a (2.38-2.30)
No. of molecules/ASU 1 1
No. of unique
reflections
15231 12581
Completeness (%) 99.2 (98.0) 99.1 (96.2)
Redundancy 4.5 3.2
Rsym
b 0.157 (0.419) 0.068 (0.312)
Mean I/s(I) 7.9 (1.9) 16.7 (3.3)
Wilson B value (A˚2) 25.3 33.7
Refinement
Rfactor 0.234 0.188
Rfree 0.248 0.222
Rmsd
Bond length, A˚ 0.008 0.007
Bond angle,  1.6 1.5
No. of atoms
Protein 1770 1704
Peptide 145 61
Ligand 10 (NOG) 19 (B)
Water 155 126
<Bfactor > A˚
2
Protein 23.8 32.0
Peptide 33.7 54.2
Ligand 19.6 (NOG) 13.9 (B)
Metal 12.9 (Mn) 16.1 (Fe)
Water 34.3 39.4
aHighest-resolution shell is shown in parentheses.
bRsym =
PjI < I > j/PI, where I is the intensity of an individual measure-
ment and < I > is the average intensity from multiple observations.release of the hydroxylated product from the PHD active site.
Although further work is required on longer HIFa fragments, in
solution the overall structure of the 19-residue CODD peptide
appears to be significantly disordered in both hydroxylated
and unhydroxylated forms (Ehrismann et al., 2007; Hon et al.,
2002; Koivunen et al., 2006; McNeill et al., 2005; Min et al.,
2002). The apparent disordered nature of free CODD in solution
compared with its structures when bound to PHD2 (and very
likely the other PHDs) might enable it to adopt different confor-
mations when bound to the PHDs or the VCB complex. It is
possible that trans-4-prolyl hydroxylation, with the associated
C4 exo bias, might enable local ‘‘preorganization’’ of the CODD
to favor binding to the VCB complex, in a manner somewhat
analogous to the preorganization theory of enzyme catalysis
(Warshel, 1998).
As predicted by sequence and substitution analyses (Epstein
et al., 2001; Kaelin, 2005; Schofield and Ratcliffe, 2004), the
metal ion of tPHD2 is coordinated by a facial triad of residues
(His-313, Asp-315, His-374); the NOG binds to the metal in a
bidentate manner with a water molecule completing an octahe-
dral coordination geometry (Figure 3C). In catalysis by 2OG oxy-
genases, 2OG binding precedes that of substrate, with oxygen
(at least normally) binding last (Figure 4) (Clifton et al., 2006; Hau-
singer, 2004). PHD2 is unusual among studied 2OG oxygenases
in that that it forms an unusually stable complex with Fe(II) and
2OG—indeed in recombinant form it can be purified as its
Fe(II) and 2OG complex (Clifton et al., 2006; McNeill et al.,
2005). In the tPHD2.CODD complex, the metal-bound water is
positioned to hydrogen bond to the noncoordinating oxygen of
Asp-315PHD2, apparently positioned to secure the Fe(II) in a
6-coordinate state; such an arrangement is proposed to help
to prevent turnover of 2OG to succinate and CO2 in the absence
of substrate (HIFa in the case of PHD2) by hindering binding of
oxygen to the iron (Neidig et al., 2007). This arrangement might
enable PHD2 to form a stable complex with Fe(II) and 2OG in
the absence of HIFa and to slow the binding of oxygen to the
metal ion in the presence of HIFa. The NOG 1-carboxylate is
positioned in the coordination site adjacent to Pro-564CODD;
molecular dynamics simulations studies predict that 2OG will
bind similarly (Figure S4), thus the dioxygen must either bind to
the Fe(II) at the less accessible metal coordination site located
at the interior of the active site, or the 2OG 1-carboxylate must
rearrange to enable oxygen binding trans to His-374 (Figure 4)
(Zhang et al., 2002). Coupled to the limited access to the active
site iron (Figure 1), in part due to the position of the b2b3/loop,
this arrangement might (in part) cause the higher KM values
observed for oxygen than the 2OG cosubstrate or HIFa (Ehris-
mann et al., 2007; Hirsila et al., 2003); this observation also
contrasts with crystallographic studies on the asparaginyl-
hydroxylase factor inhibiting HIF (FIH, Figure 3C) (Elkins et al.,
2003; Hewitson et al., 2002), which unlike PHD2 does not appear
to form an unusually stable Fe(II).2OG complex in the absence of
HIFa and might play a less important role than PHD2 in the
human hypoxic response—at least under ‘‘normal’’ conditions.(D) The tPHD2.CODD complex showing mutation sites (highlighted in white).
(E) 2OG turnover activity of wild-type (wt) and variant tPHD2 using NODD (blue) and CODD (red) substrates. 2OG turnover in absence of substrate was sub-
tracted. Errors are standard deviations (n R 3).
(F) Substrate hydroxylation and selectivity of wt and variant tPHD2 as determined by MALDI-TOF MS using CODD and NODD substrates.
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line Residues to PHD2 and VCB
(A and B) Comparisons of the Pro-564CODD con-
formations when bound to tPHD2 (A, green) and
VCB (B, wheat). Superimposition of CODD (yellow)/
CODDHyp564 (purple) in complex with tPHD2 /VCB
yielded rmsd of 2.6 A˚ for 14 residues (561–574, Ca
atoms). The Pro-564CODD C
4-methylene is in the endo
conformation when bound to tPHD2 and the exo con-
formation when Hyp-564CODD is bound to the VCB
complex. The C4 Pro-564 hydrogen(s) are modeled
in black.
(C) Stereo view of coordination at the PHD2 (green)
and the FIH (blue) active site; note the alternative posi-
tion of the NOG 1-carboxylate. In the PHD2 structure,
NOG (orange) chelates the metal via one of its carbox-
ylate oxygens (O-Mn[II]; 2.4 A˚; trans to His-374 N32
(N2-Mn[II]; 1.9 A˚) and its amide a-carbonyl oxygen
(Oa-Mn(II); 2.1 A˚; trans to Asp-315 Od1; 2.0 A˚). The
metal-ligated water (in red) is positioned trans to
His-313 (N32-Mn[II]; 2.0 A˚; H2O-Mn[II], 2.2 A˚) and is
positioned to hydrogen bond with Asp-315 Od2
(Od2-water; 2.4 A˚).Conclusions
The central importance of the PHDs (and, in the case of humans
in particular, PHD2) to the hypoxic response is now established.
However, a detailed molecular understanding of how the PHDs
act as sensors is only just beginning to emerge. The structure
of tPHD2 in complex with CODD reported here provides a plat-
form from which detailed investigations into the mechanism
and selectivity of the PHDs can be investigated.
It is of particular interest that the b2b3/loop (residues 237–
254) plays an important role in isolating the active site and in
determining the substrate selectivity of the PHDs (Flashman
et al., 2008). Although conformational changes have been
observed upon substrate binding by other 2OG oxygenases
including FIH and a histone methyllysyl demethylase (Clifton
et al., 2006; Elkins et al., 2003; Ng et al., 2007; Roach et al.,
1997; Strieker et al., 2007), those observed for PHD2 are signif-
icantly larger. As further structures of 2OG complexes that cata-
lyze posttranslational modifications become available, it will be
of interest to see if they reveal similarly large conformational
changes on substrate binding. It should be noted that crystallo-
graphic analyses might underestimate the extent of such
changes (Bleijlevens et al., 2008; Stubbs et al., 2009).
It will nowbe possible to initiate studies aimed at identifying the
precise structural features that cause the apparently ‘‘unusual’’
properties of PHD2 relative to other studied 2OG oxygenases
(Loenarz and Schofield, 2008), including its ability to form a rela-
tively stable complex with Fe(II) and 2OG (McNeill et al., 2005).
The tPHD2.CODD complex structure will also help to enable
dissection of the factors involved in determining the NODD/
CODD selectivity of the human PHDs. The crystallographic
studies also support the proposal that hydroxylation effects
a bias in the proline ring structure via operation of the ‘‘gauche’’
stereoelectronic effect: from a C4 endo to a C4 exo conformation
(Gorres et al., 2008; Loenarz et al., 2009). As further studies and
mechanistic data emerge, it will be of interest to see if this stereo-
electronic effect is relevant to catalysisbyother2OGoxygenases.
The structures will also be of importance in work aimed at the
identification of inhibitors of the human PHDs, an objective ofinterest for the treatment of anemia and ischemic disease. The
combined structures enable categorization of metal chelating
PHD inhibitors into (i) those, such as NOG, that both coordinate
the metal and allow HIFa substrate binding with the mobile
b2b3/loop (residues 237–254) in the ‘‘closed’’ position (as in
crystal formP212121); and (ii) those, such as A and B, that chelate
the metal but hinder both substrate binding and that of the b2b3/
loop in the closed position (notably by disrupting the enzyme
Arg-252:Asp-254 salt bridge), forcing the b2b3/loop toward the
open conformation as observed in the P63 crystal form
(Figure 2C).
EXPERIMENTAL PROCEDURES
Construct Design, Expression, and Purification
cDNA encoding for tPHD2 (PHD2181-426), which is reported to be similarly
active to the full-length PHD2 (Choi et al., 2005), was cloned into the
pET28a(+)/pET24a(+) vectors (Novagen), as described elsewhere (McNeill
et al., 2005), to yield tPHD2 protein with/without an N-terminal His6-tag. Stra-
tagene’s QuikChange Site-Directed Mutagenesis Kit was used to make all
point mutations using the PHD2(181-426) plasmid construct as template. Variant
or wild-type PHD2(181-426) constructs were transformed into the E. coli BL21
DE3 cell line and protein expression was induced with 0.5 mM isopropyl-b-
D-thiogalactosidase (3–5 hr at 28C). Cells were harvested and lysed by soni-
cation in 20 mM Tris-HCl (pH 7.0) and 0.3 M NaCl; soluble protein (5% total
soluble extract) was purified by immobilized Ni2+ affinity chromatography
using pentadentate Tris-carboxymethyl ethylene diamine resin followed by
cleavage of the His6-tag by thrombin (or alternately by cation exchange) and
a final purification by gel filtration. Proteins were exchanged into 50 mM
Tris-HCl buffer (pH 7.5) and concentrated to % 40 mg/ml. Proteins were of
> 95% purity, as determined by SDS-PAGE; proteins were characterized by
MS analyses under nondenaturing and denaturing conditions.
Peptides
HIF-1aNODD (395–413) and CODD (556–574) peptides used for all crystalliza-
tion trials and activity assays were from Peptide Protein Research Ltd.,
Fareham, UK.
Assay Conditions
Purified recombinant enzymes and synthetic peptides were tested for their
ability to stimulate PHD-dependent decarboxylation of 1-[14C]-labeled 2OG,
as described previously (Hewitson et al., 2002; Sabourin and Bieber, 1982).
Structure
Prolyl Hydroxylase-HIF StructuresFigure 4. Outline Catalytic Cycle for PHD2 Showing the Proposed Ferryl and Other Intermediates, Highlighting (Boxed) the Proposed Switch
in the Pro-564 Ring Conformation
Work with other 2OG oxygenases suggests it is possible that oxygen binding occurs either trans to His-313PHD2 or trans to His-374PHD2 (Zhang et al., 2002) (see
Figure 3C).Standard assay conditions comprised a total volume of 100 ml: 50mMTris-HCl
(pH 7.5), 4 mM ascorbate, 288 mM 2OG, 3.7 mM 1-[14C]-2OG (specific activity
56.8 mCi$nmol1, stock concentration 1.83 mM), 100 mM FeSO4$7H2O, 0.66
mg$ml1 catalase (H2O2 scavenger), 4 mM enzyme, and 100 mM substrate.
Briefly, the assay was set up in three drops, one containing enzyme (10 ml
40 mM), another containing substrate (10 ml 1 mM), and the third (80 ml) contain-
ing all other reagents in a 5 ml tube. A 0.5 ml Eppendorf vial containing 200 ml
hyamine hydroxide was added and the tube was then sealed with a rubber
septum. The reaction mixtures were incubated with shaking at 37C for 15
min and then quenched with methanol (200 ml). Reaction tubes were then
kept on ice for 20min, before the hyamine hydroxide was removed and treated
with scintillant liquid for radioactive count measurement in dpm (Beckman,
LS6500). Conversion of 2OG was calculated from the percentage of 1-[14C]-
2OG that had been converted to 14CO2 gas. Assays were performed in tripli-
cate and were repeated for consistency.
Hydroxylation of peptides was analyzed using a matrix-assisted laser
desorption/ionization time-of-flight (MALDI-TOF) microMX mass spectrom-
eter (Waters Micromass) in the negative ion reflectron mode. Assay conditions
utilized similar 2OG turnover assay conditions except without the radioactive
2OG. Reactions were quenched with an equal volume of 0.1% formic acid
and MeOH at 4C. All samples for MS analyses were mixed with a-cyano-4-
hydroxy-cinnamic acid (CHCA) as MALDI matrix (LaserBio Labs) (1:1) andStructure 17,spotted onto the target plate. Control experiments using equimolar amounts
of nonhydroxylated and proline-4-hydroxylated peptides (10 ml to 50 mM
each) suggested that an addition of 16 Da corresponding to hydroxyl group
might not significantly interfere with the ionization/desorption of the peptides.
The following conditions were used: source voltage = 12,000 V, reflectron
voltage = 5,200 V, pulse voltage = 1,950 V, microchannel plate detector
voltage = 2,350 V, laser energy = 100%–150%, matrix suppression = 800
amu, and TLF delay = 500 ns.
Nondenaturing Mass Spectrometry (Electrospray Ionization)
Analysis of tPHD2
For nondenaturingMSmeasurements, PHD2 solutions were buffer exchanged
into 15 mM ammonium acetate buffer (pH 7.5). Spectra were obtained on
a Waters Q-TOF mass spectrometer (Q-TOF micro, Micromass) with a chip
voltage of 1.70 kV ± 0.2 kV and a delivery pressure of 0.25 psi (1 psi = 6.89
kPa) using a NanoMate HD Robot chip-based nanoelectrospray device
(Advion Biosciences). Calibration and sample acquisitions were performed in
the positive ion mode in the range of 500–5000 m/z. Typically, 15 mM protein
samples were sprayed at a cone voltage of 80 V (alternately, 50 V and 200 V
wherever mentioned) with acquisition/scan times of 10 s/1 s. The pressure
at the interface between the atmospheric source and the high vacuum region
was 6.60 mbar. Data were processed using MASSLYNX 4.0 (Waters).981–989, July 15, 2009 ª2009 Elsevier Ltd All rights reserved 987
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Crystallization screenswere carried out in 96-well Greiner crystallization plates
using a Cartesian Dispensing Robot (Genomic Solutions Ltd.) at the Oxford
Protein Production Facility (Walter et al., 2005). Crystals of tPHD2.CODD
complexwere obtained at 20Cusing 200 nl drops (100 nl protein [40mg$ml1]
in 50 mM Tris-HCl (pH 7.5)/1 mM MnCl2/1 mM NOG/0.1 mM HIF-1a
CODD556-574 plus 100 nl well solution). The well solution consisted of 0.2 M
MgCl2 and 20% polyethylene glycol 3350. The crystals were transferred
directly to a 30% glycerol/70% well cryosolution and frozen in liquid N2. A
tPHD2.Fe(II).B.CODD568-574 crystal was obtained by soaking preformed
PHD2181-426.Fe(II).B crystals in 50% sodium malonate (pH 7.5) solution con-
taining 10 mM 4R-hydroxylated Pro-564 HIF-1a CODD556-574(Hyp564) peptide
under anaerobic conditions for 72 hr. tPHD2.Fe(II).A/B crystals were obtained
as described previously (McDonough et al., 2006). Stock solutions of all 2OG
analogs were prepared using 100%DMSO to a final concentration of 100mM.
Data Collection and Processing
All data sets were collected on single crystals at 100 K. The data set for the
tPHD2.CODD complex was collected at the ESRF microfocus beamline
ID23-2 equipped with a MarMOSAIC 225 CCD detector. The tPHD2.Fe(II).B.
CODD556-574(Hyp 564) data set was obtained at Daresbury SRS-10.1 equipped
with a MarMOSAIC 225 CCD detector. Data were integrated and scaled using
HKL2000 (Otwinowski and Minor, 1997).
Structure Solution by Molecular Replacement and Refinement
The structures were solved by molecular replacement using PHASER (McCoy
et al., 2007) (search model PDB ID 2G19). Parameter and topology files for
compounds B were generated using PRODRG (Schuttelkopf and van Aalten,
2004) for refinement in CNS (Brunger et al., 1998). Iterative cycles of model
building in COOT (Emsley and Cowtan, 2004) and slowcool-simulated anneal-
ing refinement by using the maximum-likelihood function and bulk-solvent
modeling in CNS proceeded until the decreasing Rfactor/Rfree no longer
converged. PROCHECK (Laskowski et al., 1993) was used to monitor the
geometric quality of the model between refinement cycles and pick out poorly
modeled areas needing attention. Water molecules were added to peaks >
1.8s in 2Fobs Fcalc electron density maps that were within hydrogen bonding
distance to protein with reasonable hydrogen bonding geometry.
ACCESSION NUMBERS
Atomic coordinates and structure factors for the reported crystal structures
have been deposited in the PDB (www.pdb.org) with the ID codes 3HQR
and 3HQU.
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